ASSESSMENT BY CONTINUOUS CARDIAC MONITORING OF MINIMUM DURATION OF PREOPERATIVE PROPRANOLOL TREATMENT IN THYROTOXIC PATIENTS

Publisher Website
Google Scholar
Abstract
The effect of the .beta.-blocker, propranolol (40 mg 6-hourly orally) was studied on the tachycardia of 6 patients with untreated thyrotoxicosis. Heart rate was monitored continuously using a light portable ECG recorder which allowed the patients to undertake normal activities during the recording periods. The most marked reduction in heart rate was evident at 24 h after starting propranolol treatment. In 3 of the patients there was only a minor further fall in heart rate despite continued propranolol administration, but in the remaining patients the reduction in heart rate with each successive day of treatment was more marked. If propranolol were to be used alone in the preparation of patients before partial thyroidectomy for thyrotoxicosis, a dose of 40 mg 6-hourly for 3-4 days might be sufficient.